AMD Drug Can Prevent Vision Loss in Diabetics With Diabetic Macular Edema
RPB-supported researchers at the University of Southern California (USC) report that ranibizumab (sold as Lucentis) can help Hispanic and non-Hispanic whites with diabetic macular edema (DME) in the United States avoid visual impairment and blindness. Diabetic retinopathy and DME are the leading causes of vision loss in working-age adults in the United States.
February 20, 2015
Related News: Top Story
Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants
RPB launches awards in data science and Diabetic Eye Disease.
Vision Research Funding Partnership Event Takes Place Today
Leaders of organizations that fund vision research convene in Washington DC to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Understanding Corneal Injuries in Dry Eyes
An RPB grantee makes a key discovery involving genes that are essential for eye health.
Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research
RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.
RPB Supporters Save Sight on Giving Tuesday
We welcome your generosity to help us meet our goal!
An RPB Awardee Tackles Inherited Retinal Diseases
Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2023 Research to Prevent Blindness. All Rights Reserved.
